PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Company ReportsMundipharma
Mundipharma
Mundipharma International Limited is a British multinational research-based pharmaceutical company owned by members of the Sackler family with locations in United Kingdom, Canada, Germany, and Singapore. In Germany, Mundipharma is a subsidiary of Mundipharma International Limited and Mundipharma AG. Its global headquarters located at the Cambridge Science Park of Cambridge, England.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Cegfila (previously pegfilgrastim mundipharma)Pegfilgrastim2019-12-19
NyxoidNaloxone2017-11-092024-2041
PelmegPegfilgrastim2018-11-20
RezzayoRezafungin2023-03-222032-2038
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Pegfilgrastim
Antithrombin iii
Ademetionine
Sodium chloride
Aspartame
Bevifimod
1
2
3
4
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use